𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation

✍ Scribed by M.K. Gjertsen; J. Breivik; I. Saeterdal; E. Thorsby; G. Gaudernack; A. Bakka; O. So̸reide; B.G. Solheim

Book ID
118559430
Publisher
The Lancet
Year
1995
Tongue
English
Weight
316 KB
Volume
346
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

p21-ras-peptide-specific T-cell response
p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly → Asp)
✍ Beate Fossum; Tobias Gedde-Dahl III; Jarle Breivik; Jon Amund Eriksen; Anne Spur 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 979 KB

Peptides derived from mutated ras are immunogenic in mice and humans, and represent a group of specific tumor antigens that are potential targets for immunotherapy. T-cell responses against mutant p2I ras can be initiated in vitro by repeated stimulation of peripheral-blood mononuclear cells with mu

Cytotoxic CD4+ and CD8+ T lymphocytes, g
Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12VAL) peptide vaccination of a patient, recognize 12VAL-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation
✍ Marianne K. Gjertsen; Jens Bjørheim; Ingvil Saeterdal; June Myklebust; Gustav Ga 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 French ⚖ 119 KB 👁 1 views

Mutant p21-ras proteins contain sequences that distinguish them from normal ras, and represent unique epitopes for T-cell recognition of antigen-bearing tumour cells. Here, we examined the capacity of CD4 ؉ and CD8 ؉ T cells, generated simultaneously by mutant-ras-peptide vaccination of a pancreatic